Decibel Rising: Startup Tackles Inner-Ear Indications, Including Drug-Implant Combinations
This article was originally published in The Gray Sheet
Executive Summary
The newly launched pharma startup Decibel Therapeutics wants to become the definitive inner-ear specialist, including combining its know-how with cochlear implant makers to improve that treatment and perhaps allow those devices to be miniaturized and be made more broadly applicable.